GALZIN
LOE Approachingzinc acetate
NDAORALCAPSULE
Approved
Jan 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
GALZIN (zinc acetate) is clinical pharmacology introduction wilson's disease (hepatolenticular degeneration) is an autosomal recessive metabolic defect in hepatic excretion of copper in the bile, resulting in accumulation of excess copper in the liver, and subsequently in other organs, including the brain, kidneys, eyes, bone, and muscles. First approved in 1997.
Drug data last refreshed 1h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
GALZIN (zinc acetate) is an oral small-molecule therapeutic for Wilson's disease, a rare autosomal recessive copper metabolism disorder causing hepatic and neuropsychiatric damage. The drug blocks intestinal copper absorption and reabsorption by inducing metallothionein production in enterocytes, thereby facilitating copper excretion in stool. It is used for maintenance therapy in Wilson's disease patients after initial chelation-based symptom stabilization.
LOE Approaching
As LOE approaches, commercial team focus shifts toward lifecycle extension strategies and brand defense rather than growth; team size likely stable or contracting.
Mechanism of Action
CLINICAL PHARMACOLOGY Introduction Wilson's disease (hepatolenticular degeneration) is an autosomal recessive metabolic defect in hepatic excretion of copper in the bile, resulting in accumulation of excess copper in the liver, and subsequently in other organs, including the brain, kidneys, eyes,…
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.